Entrepreneurial Academics: From idea to commercial reality

Innovation and new ideas come naturally to academic researchers. What if you believe that your idea has the commercial potential to become the next big thing?  Where do you start and how do you follow your idea through to setting up a successful company?

Nexxus invites you to hear from three entrepreneurial academics who have taken the leap to commercialise their ideas. Find out what they did, how they did it, what’s next and what they would do differently given the opportunity. 

Chair 

Dr Chris Hillier, Professor of Physiology, Glasgow Caledonian University

Speakers

Andrew Mearns-Spragg, Chief Technology Officer, Aquapharm Biodiscovery, Oban.
Aquapharm have a number of compounds in pre-clinical development with a focus on the development of anti-infectives for use against infections such as Acinetobacter baumannii, Pseudomonas aeruginosa and MRSA.

David Bunton, Chief Executive Officer, Biopta, Glasgow.
A spin-out company from Glasgow Caledonian University, Biopta was set up by Dr David Bunton and Professor Chris Hillier in 2002 to develop services and technology which could reduce the 90 per cent failure rate of drugs in clinical trials.

Marie-Claire Parker, Chief Executive Officer, XstalBio, Glasgow.
Spun out of the Universities of Glasgow and Strathclyde, XstalBio is an advanced drug delivery company specialising in the formulation and stabilisation of biological molecules and peptides, DNA and vaccines using XstalBio's proprietary platform technologies.

To register online for this free event please follow link to the website

http://www.nexxusscotland.com/events/show/1290

or contact Judy Rudd at j.rudd@nexxusscotland.com